| Antitumor activity of nivolumab on hemodialysis after renal allograft rejection M Ong, AM Ibrahim, S Bourassa-Blanchette, C Canil, T Fairhead, G Knoll Journal for ImmunoTherapy of Cancer 4, 1-5, 2016 | 84 | 2016 |
| The risk of diarrhea and colitis in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis P Tandon, S Bourassa-Blanchette, K Bishay, S Parlow, SA Laurie, ... Journal of immunotherapy 41 (3), 101-108, 2018 | 73 | 2018 |
| Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta‐analysis S Bourassa‐Blanchette, GA Knoll, B Hutton, N Fergusson, A Bennett, ... Clinical transplantation 33 (6), e13560, 2019 | 28 | 2019 |
| The risk of diarrhea and colitis in patients with lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis K Bishay, P Tandon, S Bourassa-Blanchette, SA Laurie, JD McCurdy Current Oncology 27 (5), 486-494, 2020 | 19 | 2020 |
| The median effective seated time for hypotension induced by spinal anesthesia at cesarean delivery with two doses of hyperbaric bupivacaine: a randomized up-down sequential … A Moore, S Bourrassa-Blanchette, E El Mouallem, I Kaufman, ... Canadian Journal of Anesthesia 61 (10), 916-921, 2014 | 14 | 2014 |
| Angioinvasive mucormycosis and paradoxical stroke: a case report R Mititelu, S Bourassa-Blanchette, K Sharma, V Roth JMM case reports 3 (4), e005048, 2016 | 12 | 2016 |
| Brain reorganization after endovascular treatment in a patient with a large arteriovenous malformation: the role of diagnostic and functional neuroimaging techniques R La Piana, S Bourassa-Blanchette, D Klein, K Mok, MDPC Nino, ... Interventional Neuroradiology 19 (3), 329-338, 2013 | 10 | 2013 |
| A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers S Bourassa‐Blanchette, G Knoll, J Tay, C Bredeson, DW Cameron, ... Transplant Infectious Disease 19 (4), e12706, 2017 | 8 | 2017 |
| 453-the risk of diarrhea and colitis in patients with lung cancer undergoing immune-checkpoint inhibitor therapy K Bishay, P Tandon, S Bourassa-Blanchette, S Parlow, S Laurie, ... Gastroenterology 154 (6), S-104-S-105, 2018 | 2 | 2018 |
| P118 THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY P Tandon, S Bourassa-Blanchette, K Bishay, S Parlow, SA Laurie, ... Gastroenterology 154 (1), S60, 2018 | | 2018 |
| Le temps médian assis efficace pour l’hypotension induite par la rachianesthésie pour césarienne avec deux doses de bupivacaïne hyperbare: étude randomisée avec méthode d … A Moore, S Bourrassa-Blanchette, E El Mouallem, I Kaufman, ... Canadian Journal of Anesthesia/Journal canadien d'anesthésie 61, 916-921, 2014 | | 2014 |
| JMM Case Reports S Bourassa-Blanchette, MK Sharma, MBA Virginia Roth | | |
